Recent studies [40,41] have demonstrated overexpression of PDX1 and alterations in HES1 expression not only in ductal pancreatic adenocarcinoma, but also in cholangiocarcinoma and biliary intraepithelial neoplasia. This evidence concerns the gene PDX1 and pancreatic ductal adenocarcinoma.